VANI(VANI)
VANI
Key MetricsTTM
Market Cap$68.24M
Revenue TTM$0.00
Net Income TTM-$27.09M
Free Cash Flow-$26.52M
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
Return on Equity-264.0%
Return on Assets-64.0%
Debt / Equity0.96
Current Ratio3.18
EPS TTM$-0.33
PRICE
Prev Close
1.19
Open
1.17
Day Range1.15 – 1.18
1.15
1.18
52W Range0.92 – 1.92
0.92
1.92
24% of range
VOLUME & SIZE
Avg Volume
242.5K
FUNDAMENTALS
P/E Ratio
-2.9x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
1.23
Market-like
TECHNICAL
RSI (14)
50
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 23
DEx-Dividend
In 90 days
Aug 20
PDividend Pay
In 96 days
Aug 26
VANI News
About
vivani leverages proprietary technologies to develop and commercialize drug and device implants, including its lead asset npm-119 (exenatide implant), which seeks to treat patients with chronic diseases with high unmet medical need.
Sector
Industry
Surgical and Medical Instrument Manufacturing
Anthony Edward BaldorChief Financial Officer
Donald DwyerChief Business Officer & Corporate Secretary
Truc LeChief Operations Officer
Adam MendelsohnCo-Founder, Chief Executive Officer & Director
Lisa E. PorterChief Medical Officer